Shimiao Zhu, Changyi Quan. "Adjuvant toripalimab in high-risk renal cell carcinoma after tumor resection (TUOAD-RCC): A prospective phase 2 study.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.e16520